Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedMaryland is added under Locations and Maryland Locations is removed, with the page revision updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no substantive changes to the study details are visible.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the funding-lapse notice warning that information on this site may not be up to date.SummaryDifference0.4%

- Check69 days agoChange DetectedNo additions or deletions were detected. The page content appears unchanged.SummaryDifference0.4%

- Check97 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

- Check105 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.1%

Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.